UniProt ID | ANDR_HUMAN | |
---|---|---|
UniProt AC | P10275 | |
Protein Name | Androgen receptor | |
Gene Name | AR | |
Organism | Homo sapiens (Human). | |
Sequence Length | 920 | |
Subcellular Localization | Nucleus . Cytoplasm . Detected at the promoter of target genes (PubMed:25091737). Predominantly cytoplasmic in unligated form but translocates to the nucleus upon ligand-binding. Can also translocate to the nucleus in unligated form in the presence o | |
Protein Description | Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription factor activity is modulated by bound coactivator and corepressor proteins. Transcription activation is down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3.; Isoform 3 and isoform 4 lack the C-terminal ligand-binding domain and may therefore constitutively activate the transcription of a specific set of genes independently of steroid hormones.. | |
Protein Sequence | MEVQLGLGRVYPRPPSKTYRGAFQNLFQSVREVIQNPGPRHPEAASAAPPGASLLLLQQQQQQQQQQQQQQQQQQQQQQQETSPRQQQQQQGEDGSPQAHRRGPTGYLVLDEEQQPSQPQSALECHPERGCVPEPGAAVAASKGLPQQLPAPPDEDDSAAPSTLSLLGPTFPGLSSCSADLKDILSEASTMQLLQQQQQEAVSEGSSSGRAREASGAPTSSKDNYLGGTSTISDNAKELCKAVSVSMGLGVEALEHLSPGEQLRGDCMYAPLLGVPPAVRPTPCAPLAECKGSLLDDSAGKSTEDTAEYSPFKGGYTKGLEGESLGCSGSAAAGSSGTLELPSTLSLYKSGALDEAAAYQSRDYYNFPLALAGPPPPPPPPHPHARIKLENPLDYGSAWAAAAAQCRYGDLASLHGAGAAGPGSGSPSAAASSSWHTLFTAEEGQLYGPCGGGGGGGGGGGGGGGGGGGGGGGEAGAVAPYGYTRPPQGLAGQESDFTAPDVWYPGGMVSRVPYPSPTCVKSEMGPWMDSYSGPYGDMRLETARDHVLPIDYYFPPQKTCLICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRNDCTIDKFRRKNCPSCRLRKCYEAGMTLGARKLKKLGNLKLQEEGEASSTTSPTEETTQKLTVSHIEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Phosphorylation | QLGLGRVYPRPPSKT EECCCCCCCCCCCCC | 7.68 | 25002506 | |
16 | Phosphorylation | RVYPRPPSKTYRGAF CCCCCCCCCCHHHHH | 40.07 | 12015328 | |
18 | Phosphorylation | YPRPPSKTYRGAFQN CCCCCCCCHHHHHHH | 23.84 | 25002506 | |
19 | Phosphorylation | PRPPSKTYRGAFQNL CCCCCCCHHHHHHHH | 15.70 | 25002506 | |
29 | Phosphorylation | AFQNLFQSVREVIQN HHHHHHHHHHHHHHC | 18.79 | 27499020 | |
81 | Phosphorylation | QQQQQQQETSPRQQQ HHHHHHHHCCHHHHH | 19.82 | 12015328 | |
83 | Phosphorylation | QQQQQETSPRQQQQQ HHHHHHCCHHHHHHH | 46.86 | 12015328 | |
94 | Phosphorylation | QQQQQGEDGSPQAHR HHHHHCCCCCCCHHH | 26.59 | 20363803 | |
96 | Phosphorylation | QQQGEDGSPQAHRRG HHHCCCCCCCHHHCC | 52.04 | 30278072 | |
119 | Phosphorylation | EEQQPSQPQSALECH CCCCCCCCCHHHHHC | 41.31 | 12015328 | |
121 | Phosphorylation | QQPSQPQSALECHPE CCCCCCCHHHHHCCC | 9.75 | 12015328 | |
142 | Phosphorylation | PGAAVAASKGLPQQL CCHHHHHHCCCCCCC | 39.84 | 26546556 | |
206 | Phosphorylation | QEAVSEGSSSGRARE HHHHHHCCCCHHHHC | 33.71 | 11404460 | |
208 | Phosphorylation | AVSEGSSSGRAREAS HHHHCCCCHHHHCCC | 32.21 | 11404460 | |
213 | Phosphorylation | SSSGRAREASGAPTS CCCHHHHCCCCCCCC | 30.63 | 22155408 | |
215 | Phosphorylation | SGRAREASGAPTSSK CHHHHCCCCCCCCCC | 11.16 | 11404460 | |
217 | Phosphorylation | RAREASGAPTSSKDN HHHCCCCCCCCCCCC | 45.13 | - | |
219 | Phosphorylation | REASGAPTSSKDNYL HCCCCCCCCCCCCCC | 46.65 | - | |
223 | Phosphorylation | GAPTSSKDNYLGGTS CCCCCCCCCCCCCCC | 19.50 | 19060867 | |
225 | Phosphorylation | PTSSKDNYLGGTSTI CCCCCCCCCCCCCCC | 27.29 | 19060867 | |
231 | Phosphorylation | NYLGGTSTISDNAKE CCCCCCCCCCHHHHH | 25.54 | - | |
233 | Phosphorylation | LGGTSTISDNAKELC CCCCCCCCHHHHHHH | 46.23 | - | |
242 | Phosphorylation | NAKELCKAVSVSMGL HHHHHHHHHHHHCCC | 17.21 | - | |
244 | Phosphorylation | KELCKAVSVSMGLGV HHHHHHHHHHCCCCH | 10.30 | - | |
246 | Phosphorylation | LCKAVSVSMGLGVEA HHHHHHHHCCCCHHH | 16.27 | - | |
256 | Phosphorylation | LGVEALEHLSPGEQL CCHHHHHHCCCCCCC | 32.54 | 12015328 | |
258 | Phosphorylation | VEALEHLSPGEQLRG HHHHHHCCCCCCCCC | 31.72 | 12015328 | |
267 | Phosphorylation | GEQLRGDCMYAPLLG CCCCCCCCCCHHHCC | 16.05 | 20623637 | |
269 | Phosphorylation | QLRGDCMYAPLLGVP CCCCCCCCHHHCCCC | 15.61 | 20623637 | |
280 | Phosphorylation | LGVPPAVRPTPCAPL CCCCCCCCCCCCCCH | 22.04 | 20713353 | |
282 | Phosphorylation | VPPAVRPTPCAPLAE CCCCCCCCCCCCHHH | 7.20 | 20713353 | |
291 | Phosphorylation | CAPLAECKGSLLDDS CCCHHHCCCCCCCCC | 15.97 | 20713353 | |
293 | Phosphorylation | PLAECKGSLLDDSAG CHHHCCCCCCCCCCC | 8.02 | 20713353 | |
298 | Phosphorylation | KGSLLDDSAGKSTED CCCCCCCCCCCCCCC | 28.53 | 27251275 | |
300 | Phosphorylation | SLLDDSAGKSTEDTA CCCCCCCCCCCCCCH | 35.79 | 12015328 | |
301 | Phosphorylation | LLDDSAGKSTEDTAE CCCCCCCCCCCCCHH | 41.17 | 19369195 | |
302 | Phosphorylation | LDDSAGKSTEDTAEY CCCCCCCCCCCCHHC | 61.53 | 12015328 | |
303 | Phosphorylation | DDSAGKSTEDTAEYS CCCCCCCCCCCHHCC | 51.83 | 19369195 | |
307 | Phosphorylation | GKSTEDTAEYSPFKG CCCCCCCHHCCCCCC | 21.12 | 19369195 | |
308 | Phosphorylation | KSTEDTAEYSPFKGG CCCCCCHHCCCCCCC | 18.50 | 12015328 | |
309 | Phosphorylation | STEDTAEYSPFKGGY CCCCCHHCCCCCCCC | 33.78 | 19369195 | |
310 | Phosphorylation | TEDTAEYSPFKGGYT CCCCHHCCCCCCCCC | 10.64 | 12015328 | |
328 | Phosphorylation | EGESLGCSGSAAAGS CCCCCCCCCCCCCCC | 9.84 | 27251275 | |
330 | Phosphorylation | ESLGCSGSAAAGSSG CCCCCCCCCCCCCCC | 17.66 | 27251275 | |
335 | Phosphorylation | SGSAAAGSSGTLELP CCCCCCCCCCCEECC | 35.70 | 27251275 | |
336 | Phosphorylation | GSAAAGSSGTLELPS CCCCCCCCCCEECCC | 21.00 | 22210691 | |
338 | Phosphorylation | AAAGSSGTLELPSTL CCCCCCCCEECCCHH | 59.48 | 27251275 | |
346 | Phosphorylation | LELPSTLSLYKSGAL EECCCHHHHHHCCCC | 10.34 | 17045208 | |
348 | Phosphorylation | LPSTLSLYKSGALDE CCCHHHHHHCCCCCH | 18.75 | 17045208 | |
357 | Phosphorylation | SGALDEAAAYQSRDY CCCCCHHHHHCCCCC | 11.42 | 17045208 | |
359 | Phosphorylation | ALDEAAAYQSRDYYN CCCHHHHHCCCCCCC | 17.91 | 17045208 | |
362 | Phosphorylation | EAAAYQSRDYYNFPL HHHHHCCCCCCCCCH | 10.13 | 17045208 | |
363 | Phosphorylation | AAAYQSRDYYNFPLA HHHHCCCCCCCCCHH | 18.02 | 17494760 | |
364 | Phosphorylation | AAYQSRDYYNFPLAL HHHCCCCCCCCCHHH | 26.32 | 27642862 | |
365 | Phosphorylation | AYQSRDYYNFPLALA HHCCCCCCCCCHHHC | 2.79 | 17494760 | |
386 | Sumoylation | PPPHPHARIKLENPL CCCCCCCCCCCCCCC | 44.16 | - | |
386 | Sumoylation | PPPHPHARIKLENPL CCCCCCCCCCCCCCC | 44.16 | - | |
388 | Sumoylation | PHPHARIKLENPLDY CCCCCCCCCCCCCCH | 52.37 | - | |
388 | Sumoylation | PHPHARIKLENPLDY CCCCCCCCCCCCCCH | 52.37 | 11121022 | |
393 | Phosphorylation | RIKLENPLDYGSAWA CCCCCCCCCHHHHHH | 22.21 | 17045208 | |
395 | Phosphorylation | KLENPLDYGSAWAAA CCCCCCCHHHHHHHH | 17.89 | 17045208 | |
405 | Phosphorylation | AWAAAAAQCRYGDLA HHHHHHHHCHHCCHH | 26.79 | - | |
407 | Phosphorylation | AAAAAQCRYGDLASL HHHHHHCHHCCHHHH | 12.24 | - | |
422 | Phosphorylation | HGAGAAGPGSGSPSA CCCCCCCCCCCCCCH | 38.95 | 12015328 | |
424 | Phosphorylation | AGAAGPGSGSPSAAA CCCCCCCCCCCCHHH | 19.85 | 12015328 | |
426 | Phosphorylation | AAGPGSGSPSAAASS CCCCCCCCCCHHHCC | 32.03 | 12015328 | |
503 | Phosphorylation | DFTAPDVWYPGGMVS CCCCCCCCCCCCCCC | 7.58 | 19369195 | |
504 | Phosphorylation | FTAPDVWYPGGMVSR CCCCCCCCCCCCCCC | 19.70 | 19369195 | |
515 | Phosphorylation | MVSRVPYPSPTCVKS CCCCCCCCCCCCCCC | 27.31 | 18511414 | |
516 | Phosphorylation | VSRVPYPSPTCVKSE CCCCCCCCCCCCCCC | 25.88 | 22985185 | |
518 | Phosphorylation | RVPYPSPTCVKSEMG CCCCCCCCCCCCCCC | 4.05 | 28348404 | |
520 | Sumoylation | PYPSPTCVKSEMGPW CCCCCCCCCCCCCCC | 42.73 | - | |
520 | Sumoylation | PYPSPTCVKSEMGPW CCCCCCCCCCCCCCC | 42.73 | - | |
521 | Sumoylation | YPSPTCVKSEMGPWM CCCCCCCCCCCCCCC | 16.65 | - | |
521 | Sumoylation | YPSPTCVKSEMGPWM CCCCCCCCCCCCCCC | 16.65 | 11121022 | |
534 | Phosphorylation | WMDSYSGPYGDMRLE CCCCCCCCCCCCCHH | 29.32 | 20383201 | |
535 | Phosphorylation | MDSYSGPYGDMRLET CCCCCCCCCCCCHHH | 25.93 | 20383201 | |
551 | Phosphorylation | RDHVLPIDYYFPPQK HHCCCCCCEECCCCC | 14.02 | 17045208 | |
552 | Phosphorylation | DHVLPIDYYFPPQKT HCCCCCCEECCCCCE | 13.08 | 17045208 | |
578 | Phosphorylation | HYGALTCGSCKVFFK CCCEECCCCCCEEEH | 16.95 | 18511414 | |
579 | Phosphorylation | YGALTCGSCKVFFKR CCEECCCCCCEEEHH | 2.36 | 18511414 | |
606 | Acetylation | RNDCTIDKFRRKNCP CCCCCHHHHHHHCCC | 8.95 | 118298201 | |
619 | Acetylation | CPSCRLRKCYEAGMT CCCCCHHHHHHHCCH | 2.76 | 118298199 | |
630 | Acetylation | AGMTLGARKLKKLGN HCCHHHHHHHHHHCC | 65.21 | - | |
630 | Methylation | AGMTLGARKLKKLGN HCCHHHHHHHHHHCC | 65.21 | - | |
631 | Acetylation | GMTLGARKLKKLGNL CCHHHHHHHHHHCCC | 5.01 | 11971970 | |
631 | Methylation | GMTLGARKLKKLGNL CCHHHHHHHHHHCCC | 5.01 | 21273441 | |
632 | Acetylation | MTLGARKLKKLGNLK CHHHHHHHHHHCCCC | 49.33 | - | |
632 | Methylation | MTLGARKLKKLGNLK CHHHHHHHHHHCCCC | 49.33 | - | |
633 | Acetylation | TLGARKLKKLGNLKL HHHHHHHHHHCCCCC | 72.55 | 11994312 | |
633 | Methylation | TLGARKLKKLGNLKL HHHHHHHHHHCCCCC | 72.55 | 20959290 | |
634 | Acetylation | LGARKLKKLGNLKLQ HHHHHHHHHCCCCCC | 5.41 | 11971970 | |
647 | Phosphorylation | LQEEGEASSTTSPTE CCCCCCCCCCCCCCH | 42.63 | 28450419 | |
648 | Phosphorylation | QEEGEASSTTSPTEE CCCCCCCCCCCCCHH | 28.88 | 24719451 | |
649 | Phosphorylation | EEGEASSTTSPTEET CCCCCCCCCCCCHHH | 34.36 | 24719451 | |
650 | Phosphorylation | EGEASSTTSPTEETT CCCCCCCCCCCHHHH | 29.88 | 25849741 | |
651 | Phosphorylation | GEASSTTSPTEETTQ CCCCCCCCCCHHHHC | 41.56 | 25849741 | |
653 | Phosphorylation | ASSTTSPTEETTQKL CCCCCCCCHHHHCEE | 57.65 | 25072903 | |
656 | Phosphorylation | TTSPTEETTQKLTVS CCCCCHHHHCEEEHH | 27.30 | 25072903 | |
657 | Phosphorylation | TSPTEETTQKLTVSH CCCCHHHHCEEEHHH | 46.29 | 25072903 | |
761 | Methylation | SFTNVNSRMLYFAPD HCCCCCCCEEECCCH | 3.41 | - | |
791 | Phosphorylation | QCVRMRHLSQEFGWL HHHHHHHHHHHHCCC | 22.87 | 11404460 | |
792 | Phosphorylation | CVRMRHLSQEFGWLQ HHHHHHHHHHHCCCC | 57.29 | 11404460 | |
826 | Ubiquitination | VDGLKNQKFFDELRM CCCCCCCHHHHHHHH | 7.22 | - | |
837 | Acetylation | ELRMNYIKELDRIIA HHHHHHHHHHHHHHC | 46.47 | 7367661 | |
845 | Ubiquitination | ELDRIIACKRKNPTS HHHHHHCCCCCCCCC | 58.34 | 19345326 | |
846 | Ubiquitination | LDRIIACKRKNPTSC HHHHHCCCCCCCCCH | 43.82 | PubMed | |
847 | Ubiquitination | DRIIACKRKNPTSCS HHHHCCCCCCCCCHH | 53.42 | 19345326 | |
848 | Ubiquitination | RIIACKRKNPTSCSR HHHCCCCCCCCCHHH | 49.46 | PubMed | |
850 | Phosphorylation | IACKRKNPTSCSRRF HCCCCCCCCCHHHHH | 52.32 | 22584579 | |
851 | Phosphorylation | ACKRKNPTSCSRRFY CCCCCCCCCHHHHHH | 16.02 | 22584579 | |
857 | Phosphorylation | PTSCSRRFYQLTKLL CCCHHHHHHHHHHHH | 10.78 | - | |
858 | Phosphorylation | TSCSRRFYQLTKLLD CCHHHHHHHHHHHHH | 39.69 | - | |
915 | Phosphorylation | LSGKVKPIYFHTQ-- HCCCCEEEEEECC-- | 9.61 | 17045208 | |
916 | Phosphorylation | SGKVKPIYFHTQ--- CCCCEEEEEECC--- | 5.35 | 10221692 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
81 | S | Phosphorylation | Kinase | CDK9 | P50750 | GPS |
83 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
83 | S | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
83 | S | Phosphorylation | Kinase | CDK9 | P50750 | Uniprot |
96 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
213 | S | Phosphorylation | Kinase | PKB_GROUP | - | PhosphoELM |
213 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
215 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
215 | S | Phosphorylation | Kinase | PIM1 | P11309 | PSP |
223 | Y | Phosphorylation | Kinase | CSK | P41240 | GPS |
225 | Y | Phosphorylation | Kinase | FER | P16591 | PSP |
225 | Y | Phosphorylation | Kinase | CSK | P41240 | Uniprot |
267 | Y | Phosphorylation | Kinase | CSK | P41240 | GPS |
269 | Y | Phosphorylation | Kinase | ACK | Q07912 | PSP |
269 | Y | Phosphorylation | Kinase | CSK | P41240 | Uniprot |
282 | T | Phosphorylation | Kinase | AURKA | O14965 | GPS |
293 | S | Phosphorylation | Kinase | AURKA | O14965 | GPS |
307 | Y | Phosphorylation | Kinase | CSK | P41240 | GPS |
309 | Y | Phosphorylation | Kinase | CSK | P41240 | Uniprot |
310 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
310 | S | Phosphorylation | Kinase | CDK11B | P21127 | PSP |
310 | S | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
346 | Y | Phosphorylation | Kinase | CSK | P41240 | GPS |
348 | Y | Phosphorylation | Kinase | CSK | P41240 | Uniprot |
357 | Y | Phosphorylation | Kinase | CSK | P41240 | GPS |
359 | Y | Phosphorylation | Kinase | CSK | P41240 | Uniprot |
362 | Y | Phosphorylation | Kinase | CSK | P41240 | GPS |
363 | Y | Phosphorylation | Kinase | CSK | P41240 | GPS |
364 | Y | Phosphorylation | Kinase | CSK | P41240 | Uniprot |
365 | Y | Phosphorylation | Kinase | CSK | P41240 | Uniprot |
365 | Y | Phosphorylation | Kinase | ACK | Q07912 | PSP |
393 | Y | Phosphorylation | Kinase | CSK | P41240 | GPS |
395 | Y | Phosphorylation | Kinase | CSK | P41240 | Uniprot |
516 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
516 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
516 | S | Phosphorylation | Kinase | CDK7 | P50613 | PSP |
516 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
534 | Y | Phosphorylation | Kinase | CSK | P41240 | GPS |
535 | Y | Phosphorylation | Kinase | CSK | P41240 | Uniprot |
535 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
551 | Y | Phosphorylation | Kinase | CSK | P41240 | GPS |
552 | Y | Phosphorylation | Kinase | CSK | P41240 | Uniprot |
579 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
579 | S | Phosphorylation | Kinase | PAK6 | Q9NQU5 | PSP |
650 | S | Phosphorylation | Kinase | STK4 | Q13043 | GPS |
651 | S | Phosphorylation | Kinase | MST1 | P26927 | Uniprot |
651 | S | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
651 | S | Phosphorylation | Kinase | MAPK8 | P45983 | GPS |
651 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
791 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
791 | S | Phosphorylation | Kinase | PKB_GROUP | - | PhosphoELM |
792 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
851 | T | Phosphorylation | Kinase | PIM1 | P11309 | PSP |
915 | Y | Phosphorylation | Kinase | CSK | P41240 | GPS |
916 | Y | Phosphorylation | Kinase | CSK | P41240 | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | STUB1 | Q9UNE7 | PMID:12559985 |
- | K | Ubiquitination | E3 ubiquitin ligase | MDM2 | Q00987 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | RNF6 | Q9Y252 | PMID:14559117 |
- | K | Ubiquitination | E3 ubiquitin ligase | NEDD4 | P46934 | PMID:18703514 |
- | K | Ubiquitination | E3 ubiquitin ligase | SPOP | O43791 | PMID:24508459:25274033 |
- | K | Ubiquitination | E3 ubiquitin ligase | SIAH2 | O43255 | PMID:23518348 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ANDR_HUMAN !! |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
300068 | Androgen insensitivity syndrome (AIS) |
313200 | Spinal and bulbar muscular atrophy X-linked 1 (SMAX1) |
Note=Defects in AR may play a role in metastatic prostate cancer. The mutated receptor stimulates prostate growth and metastases development despite of androgen ablation. This treatment can reduce primary and metastatic lesions probably by inducing apoptosis of tumor cells when they express the wild-type receptor. | |
312300 | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB01128 | Bicalutamide |
DB04839 | Cyproterone acetate |
DB01406 | Danazol |
DB01395 | Drospirenone |
DB00858 | Drostanolone |
DB08899 | Enzalutamide |
DB00687 | Fludrocortisone |
DB01185 | Fluoxymesterone |
DB00499 | Flutamide |
DB01026 | Ketoconazole |
DB00367 | Levonorgestrel |
DB06710 | Methyltestosterone |
DB08804 | Nandrolone decanoate |
DB00984 | Nandrolone phenpropionate |
DB00665 | Nilutamide |
DB00621 | Oxandrolone |
DB00421 | Spironolactone |
DB00624 | Testosterone |
DB01420 | Testosterone Propionate |
loading...
Phosphorylation | |
Reference | PubMed |
"MST1 is a multifunctional caspase-independent inhibitor of androgenicsignaling."; Cinar B., Collak F.K., Lopez D., Akgul S., Mukhopadhyay N.K.,Kilicarslan M., Gioeli D.G., Freeman M.R.; Cancer Res. 71:4303-4313(2011). Cited for: PHOSPHORYLATION AT SER-650, AND INTERACTION WITH STK4/MST1. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-300; THR-301 ANDTYR-307, AND MASS SPECTROMETRY. | |
"CDK9 regulates AR promoter selectivity and cell growth through serine81 phosphorylation."; Gordon V., Bhadel S., Wunderlich W., Zhang J., Ficarro S.B.,Mollah S.A., Shabanowitz J., Hunt D.F., Xenarios I., Hahn W.C.,Conaway M., Carey M.F., Gioeli D.; Mol. Endocrinol. 24:2267-2280(2010). Cited for: FUNCTION IN AR KINASE, PHOSPHORYLATION AT SER-81 BY CDK9, MUTAGENESISOF SER-81, AND INTERACTION WITH CDK9. | |
"Effect of Ack1 tyrosine kinase inhibitor on ligand-independentandrogen receptor activity."; Mahajan K., Challa S., Coppola D., Lawrence H., Luo Y., Gevariya H.,Zhu W., Chen Y.A., Lawrence N.J., Mahajan N.P.; Prostate 70:1274-1285(2010). Cited for: PHOSPHORYLATION AT TYR-267, AND ENZYME REGULATION. | |
"Activated Cdc42-associated kinase Ack1 promotes prostate cancerprogression via androgen receptor tyrosine phosphorylation."; Mahajan N.P., Liu Y., Majumder S., Warren M.R., Parker C.E.,Mohler J.L., Earp H.S., Whang Y.E.; Proc. Natl. Acad. Sci. U.S.A. 104:8438-8443(2007). Cited for: INTERACTION WITH TNK2, PHOSPHORYLATION AT TYR-267 AND TYR-363 BY TNK2,AND MUTAGENESIS OF TYR-267 AND TYR-363. | |
"Regulation of androgen receptor activity by tyrosinephosphorylation."; Guo Z., Dai B., Jiang T., Xu K., Xie Y., Kim O., Nesheiwat I.,Kong X., Melamed J., Handratta V.D., Njar V.C., Brodie A.M., Yu L.-R.,Veenstra T.D., Chen H., Qiu Y.; Cancer Cell 10:309-319(2006). Cited for: PHOSPHORYLATION AT TYR-223; TYR-267; TYR-307; TYR-346; TYR-357;TYR-362; TYR-363; TYR-393; TYR-534; TYR-551 AND TYR-915, MUTAGENESISOF TYR-223; TYR-267; TYR-307; TYR-346; TYR-357; TYR-362; TYR-363;TYR-393; TYR-534; TYR-551 AND TYR-915, AND MASS SPECTROMETRY. | |
Sumoylation | |
Reference | PubMed |
"Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1)."; Poukka H., Karvonen U., Jaenne O.A., Palvimo J.J.; Proc. Natl. Acad. Sci. U.S.A. 97:14145-14150(2000). Cited for: SUMOYLATION AT LYS-386 AND LYS-520. | |
Ubiquitylation | |
Reference | PubMed |
"Regulation of androgen receptor transcriptional activity andspecificity by RNF6-induced ubiquitination."; Xu K., Shimelis H., Linn D.E., Jiang R., Yang X., Sun F., Guo Z.,Chen H., Li W., Chen H., Kong X., Melamed J., Fang S., Xiao Z.,Veenstra T.D., Qiu Y.; Cancer Cell 15:270-282(2009). Cited for: FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, POLYUBIQUITINATION ATLYS-845 AND LYS-847 BY RNF6, MUTAGENESIS OF LYS-845 AND LYS-847,INTERACTION WITH RNF14 AND RNF6, AND SUBCELLULAR LOCATION. |